Collplant Biotechnologies Ltd - ESG Rating & Company Profile powered by AI
Full ESG analysis of Collplant Biotechnologies Ltd can be accessed by logging in. This Disclosure rating includes seventeen UN SDGs including: 'Affordable & Clean Energy', 'Sustainable Cities & Communities' and 'Peace, Justice & Strong Institutions'. This Sustainability rating for Collplant Biotechnologies Ltd represents the company's transparency towards the UN SDGs.
Collplant Biotechnologies Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.4; made up of an environmental score of 2.7, social score of 6.4 and governance score of 4.0.
4.4
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 868 | Trevena Inc | 4.5 | High |
| 868 | Urogen Pharma Ltd | 4.5 | High |
| 910 | Collplant Biotechnologies Ltd | 4.4 | High |
| 910 | CanBas Co Ltd | 4.4 | High |
| 910 | CNS Pharmaceuticals Inc | 4.4 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Collplant Biotechnologies Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Collplant Biotechnologies Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Collplant Biotechnologies Ltd report the average age of the workforce?
Sign up for free to unlockDoes Collplant Biotechnologies Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Collplant Biotechnologies Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Collplant Biotechnologies Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Collplant Biotechnologies Ltd offer flexible work?
Sign up for free to unlockDoes Collplant Biotechnologies Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Collplant Biotechnologies Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Collplant Biotechnologies Ltd conduct supply chain audits?
Sign up for free to unlockDoes Collplant Biotechnologies Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Collplant Biotechnologies Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Collplant Biotechnologies Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Collplant Biotechnologies Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Collplant Biotechnologies Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Collplant Biotechnologies Ltd disclose water use targets?
Sign up for free to unlockDoes Collplant Biotechnologies Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Collplant Biotechnologies Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Collplant Biotechnologies Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Collplant Biotechnologies Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Collplant Biotechnologies Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Collplant Biotechnologies Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Collplant Biotechnologies Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Collplant Biotechnologies Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Collplant Biotechnologies Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Collplant Biotechnologies Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Collplant Biotechnologies Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Collplant Biotechnologies Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Collplant Biotechnologies Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Collplant Biotechnologies Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Collplant Biotechnologies Ltd disclose its waste policy?
Sign up for free to unlockDoes Collplant Biotechnologies Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Collplant Biotechnologies Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Collplant Biotechnologies Ltd disclose energy use targets?
Sign up for free to unlockDoes Collplant Biotechnologies Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Collplant Biotechnologies Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Collplant Biotechnologies Ltd
These potential risks are based on the size, segment and geographies of the company.
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; injectable implants to promote breast tissue regeneration; 3D bioprinted regenerative soft tissue matrix; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. It has collaboration agreements with 3D Systems Corporation; CellInk, a BICO Group company; Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; Israel's Technion Institute of Technology; AbbVie; and STEMCELL. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.